SEC Form 4 · accession 0000313143-26-000068
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Farris Maryanne Maunsell
Officer — VP, Chief Accounting Officer
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 4:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 5, 2026 | F | 259 | $71.28 | D | 6,242 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
- F2This number includes unvested RSUs previously reported.